Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine.

about

Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine.

Item

http://www.wikidata.org/entity/Q47139657

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Enhanced immune response induc ...... s a preventive cancer vaccine.

@en

Enhanced immune response induc ...... s a preventive cancer vaccine.

@nl

type

Item

label

Enhanced immune response induc ...... s a preventive cancer vaccine.

@en

Enhanced immune response induc ...... s a preventive cancer vaccine.

@nl

prefLabel

Enhanced immune response induc ...... s a preventive cancer vaccine.

@en

Enhanced immune response induc ...... s a preventive cancer vaccine.

@nl

P1476

Enhanced immune response induc ...... as a preventive cancer vaccine

@en

P2093

Jalil Tavakkol-Afshari

http://www.w3.org/2001/XMLSchema#string

Seyed Amir Jalali

http://www.w3.org/2001/XMLSchema#string

Zahra Gholizadeh

http://www.w3.org/2001/XMLSchema#string

P2860

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Priming of CD8(+) T Cell Responses to Liver Stage Malaria Parasite Antigens

Dendritic cells: specialized and regulated antigen processing machines

The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection.

Visualizing T Cell Migration in situ

Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.

Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA.

Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation.

P304

558-567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCMM.13343

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mahmoud Reza Jaafari

Amin Reza Nikpoor

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28944998

http://www.w3.org/2001/XMLSchema#string

P932

5742681

http://www.w3.org/2001/XMLSchema#string